Ra Capital Management, L.P. Legend Biotech Corp Transaction History
Ra Capital Management, L.P.
- $6.17 Billion
- Q4 2024
A detailed history of Ra Capital Management, L.P. transactions in Legend Biotech Corp stock. As of the latest transaction made, Ra Capital Management, L.P. holds 7,506,934 shares of LEGN stock, worth $265 Million. This represents 3.96% of its overall portfolio holdings.
Number of Shares
7,506,934
Previous 7,506,934
-0.0%
Holding current value
$265 Million
Previous $366 Million
33.22%
% of portfolio
3.96%
Previous 5.1%
Shares
11 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$240 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$211 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$202 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$201 Million0.86% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.5MShares$123 Million4.74% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.9B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...